Fate Therapeutics INC
SEC CIK 1434316 · fate · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Rastetter William H | Director | filed 2013 - 2026 |
| Epstein Robert S | Director | filed 2014 - 2026 |
| Redmile Group, LLC | Director · Managing Member | filed 2017 - 2026 |
| Green Jeremy | Director | filed 2017 - 2026 |
| Abernethy Matt | Director | filed 2025 - 2026 |
| Agarwal Shefali | Director | filed 2019 - 2026 |
| Lee Michael Stewart | Director | filed 2018 - 2026 |
| Hamill Laura | Director | filed 2026 - 2026 |
| Jooss Karin | Director | filed 2019 - 2026 |
| Xu Yuan | Director | filed 2021 - 2026 |
| Valamehr Bahram | Director · See Remarks | filed 2018 - 2026 |
| Redco II Master Fund, L.P. | Director | filed 2025 - 2026 |
| Mendlein John | Director | filed 2013 - 2025 |
| Mozaffarian Neelufar | Director | filed 2024 - 2025 |
| Coughlin Timothy P | Director | filed 2013 - 2024 |
| Wolchko J Scott | Director · See remarks | filed 2013 - 2024 |
| Hershberg Robert | Director | filed 2020 - 2023 |
| Nashat Amir | Director | filed 2013 - 2019 |
| Enyedy Mark J | Director | filed 2013 - 2017 |
| Weyer Christian | Director · See remarks | filed 2013 - 2015 |
| Nelsen Robert | Director | filed 2013 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Tahl Cindy | See Remarks | filed 2015 - 2026 |
| Adawi Kamal | Chief Financial Officer | filed 2025 - 2026 |
| Bressi Jerome Charles | See Remarks | filed 2024 - 2025 |
| Dulac Edward J III | Chief Financial Officer | filed 2020 - 2024 |
| Powl Brian T. | Chief Commercial Officer | filed 2022 - 2023 |
| Chu Yu-Waye | Senior VP Clinical Development | filed 2021 - 2023 |
| Plavsic Mark | Chief Technical Officer | filed 2021 - 2023 |
| Shoemaker Daniel D | Chief Technology Officer | filed 2013 - 2021 |
| Abbot Stewart | Chief Development Officer | filed 2015 - 2018 |
| Storgard Chris | Chief Medical Officer | filed 2016 - 2018 |
| Multani Pratik S | Chief Medical Officer | filed 2013 - 2015 |
| Flynn Peter D | See remarks | filed 2013 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.